Long Term Complete Response of Advanced Hepatocellular Carcinoma to Glypican-3 Specific Chimeric Antigen Receptor T-Cells Plus Sorafenib, a Case Report.
FRONTIERS IN IMMUNOLOGY(2022)
关键词
chimeric antigen receptor T cell therapy,liver cancer,hepatocellular carcinoma,glypican-3,sorafenib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要